首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 125 毫秒
1.
以肠溶性的羟丙基甲基纤维素邻苯二甲酸酯(HPMCP)作为包覆材料,制备了HPMCP包覆的SBA-15介孔分子筛药物控释载体(HPMCP/SBA-15),并考察了抗癌药物5-氟尿嘧啶(5-Fu)负载于控释载体后,在不同pH释放环境中的释放行为.结果表明,在模拟胃液中(pH=1.2),HPMCP能明显地延缓5-Fu的释放速度;药物释放4h后,其释放率仅为15%.而在模拟肠液中(pH=7.5)HPMCP迅速溶解,对5-Fu释放速度的影响甚微;药物释放4h后,释放率可达到80%.与此同时,包覆膜的干燥温度影响5-Fu的释放行为,干燥温度越高,药物在模拟胃液中的释放速度越慢.  相似文献   

2.
采用液相多肽合成方法,成功制备得到窄分子量分布、结构确定的聚乙二醇嵌段共聚四代树枝状聚赖氨酸(MPEG-block-DPL4).在此基础上,进一步将其DPL4的端氨基转化为端肼基,并通过其与抗肿瘤药物阿霉素(DOX)C=O的反应形成C=N键,实现在DPL4表面的阿霉素药物分子化学结合,最终得到新型pH敏感性的高分子药物MPEG-block-DPL4-CONHN=DOX.运用紫外分光光度(UV-Vis)法,对MPEG-block-DPL4-CONHNH2与阿霉素的负载效率进行了定量分析.高分子药物MPEG-block-DPL4-CONHN=DOX在生理条件(pH=7.4)下相对稳定,而弱酸性条件(pH=4.5,5.5)下,C=N键能较快水解,释放阿霉素药物分子.体外细胞毒性评价结果表明(细胞株SMMC-7721和SPCA-1),所得新型高分子药物MPEG-block-DPL4-CONHN=DOX的细胞毒性显著地低于游离阿霉素药物分子,因此,可进一步研究发展成为新型pH敏感性可控缓释高分子抗肿瘤药物载体体系.  相似文献   

3.
以盐酸改性蒙脱土为药物载体,采用离子交换法制备了酮洛芬/酸改性蒙脱土(KPF/acid-MMT)复合物.借助X射线衍射(XRD)、比表面积分析和扫描电子显微镜(SEM)等手段对复合物进行了结构表征;采用透析法研究了介质pH值对KPF/acid-MMT释放性能的影响;运用3种数学模型对其体外释放行为进行拟合.结果表明:经酸改性后,蒙脱土的比表面积由19.66 m~2/g增加到202.84 m~2/g,载药量由18.09%提高到37.24%;在人工模拟胃液(pH=1.2)和人工模拟肠液(pH=6.8)中,酮洛芬的累积释放量分别为18.6%和86.7%;零级动力学模型能更好地拟合和描述KPF/acid-MMT在人工模拟肠液中的体外释放行为.酸改性蒙脱土能有效提高药物的负载量,KPF/acid-MMT可实现药物的定向释放和缓释性能,有望制成肠道缓释口服药物制剂.  相似文献   

4.
丝蛋白具有良好的生物相容性,生物可降解性以及无免疫原性.利用丝蛋白独特的亲疏水多嵌段共聚物结构特征和构象转变机制,通过乙醇诱导和冷冻相结合的自组装方法制备得到丝蛋白纳米微球后,再在纳米微球表面包覆阿霉素,成功获得了负载阿霉素的丝蛋白纳米载药微球.该载药丝蛋白纳米微球的尺寸为350~400 nm,具有圆球形态并且分散性能良好;其载药率为4.6%,包封率大于90%,在磷酸缓释溶液中的释放可达7天以上.此外,研究发现其缓释行为具有pH响应性,在pH=5.0的磷酸缓冲溶液中的缓释量明显大于在pH=7.4的缓冲液中.体外细胞培养结果显示,纯丝蛋白纳米微球基本没有细胞毒性;而负载有阿霉素的丝蛋白纳米微球能明显抑制癌细胞(Hela细胞)的增殖,且24h和48 h的培养结果表现出与单纯药物相同的药效.因此,该负载阿霉素的丝蛋白纳米微球在临床癌症淋巴化疗方面具有潜在的应用价值.  相似文献   

5.
以表面接枝聚乙二醇链的聚酰胺胺树枝状聚合物(PEG-PAMAM)为纳米载体, 在其内部空腔包覆金纳米粒子, 在金纳米粒子表面连接硫辛酸改性的阿霉素(LA-DOX), 从而间接实现了抗癌药物在PEG-PAMAM内的高效负载. 同时, LA-DOX中的酰腙键提供pH响应性, 实现了药物的pH响应性释放. 紫外-可见(UV-Vis)光谱表明, 包覆金纳米粒子的PEG-PAMAM纳米载体对LA-DOX的负载能力显著增强. 体外细胞实验表明, 负载LA-DOX的树枝状聚合物-金纳米粒子复合药物载体具有较强的抗肿瘤能力.  相似文献   

6.
采用柠檬酸钠作为稳定剂,通过超声辅助水相共沉淀法合成了柠檬酸修饰的Fe_3O_4纳米粒(Fe_3O_4@CA),进一步采用真空干燥法制备了β-环糊精包覆的Fe_3O_4纳米微球(Fe_3O_4@β-CD).分别利用X射线粉末衍射仪、傅立叶变换红外光谱仪、透射电子显微镜、热重分析仪等表征手段对其进行了结构和形貌表征.同时,以多柔比星为模型药物,考察了Fe_3O_4@β-CD微球对多柔比星的体外释放行为.结果表明,Fe_3O_4@CA纳米粒子呈球形或类球形,平均流体力学直径为84nm,具有顺磁性,室温下饱和磁化强度为17.5emu·g-1,红外光谱结果表明,β-环糊精成功的包覆在Fe_3O_4@CA表面,Fe_3O_4@β-CD的平均流体力学直径为104nm,室温下饱和磁化强度为15.7emu·g-1.体外释放结果表明,Fe_3O_4@β-CD-DOX载药系统在PBS(pH=7.4)溶液中释放缓慢,12h累积释放率为45.5%.结果表明,环糊精改性的Fe_3O_4纳米微球在体外有明显的缓释效果,有望成为理想的抗肿瘤药物载体.  相似文献   

7.
本文以壳聚糖(CS)、聚乙二醇(PEG)和丙烯酸(AA)为原料,制备了复合水凝胶CS/PEG/PAA。研究了负载四种具有不同结构和性质的药物(烟酸、烟酰胺、异烟肼和5-氟尿嘧啶)的复合水凝胶CS/PEG/PAA的药物控制释放行为。结果表明,烟酰胺和异烟肼在pH=1.80的缓冲溶液中的药物累积释放率(R)大于其在pH=6.86的缓冲溶液中的释放率;烟酸却在pH=6.86的缓冲溶液中的药物累积释放率(R)大于其在pH=1.80的缓冲溶液中的释放率。而5-氟尿嘧啶在两种缓冲溶液中的药物累积释放量相当。因此,复合水凝胶CS/PEG/PAA也许可以作为一种新型释放药物的载体。  相似文献   

8.
利用溶液法预先制备壳聚糖(Cs)-蒙脱土(MMT)复合材料(Cs-MMT),以Cs-MMT、Cs为原料,采用反相悬浮聚合法制得一种新型药物缓释体系阿司匹林-蒙脱土-壳聚糖载药微球(Asp-MMT-Cs)。采用FT-IR、SEM表征了Cs-MMT和Asp-MMT-Cs载药微球的结构及形态;设计正交实验优化了Asp-MMT-Cs载药微球的制备工艺;通过体外释放实验探讨了载药微球在不同模拟释放液中的释药规律。结果表明:所得微球球形度好,粒径分布较均匀;最优工艺制得的载药微球平均粒径为81.20μm,载药量为9.61%,包封率为76.78%。该缓释体系具有pH敏感性,更倾向于在pH较高的磷酸盐缓冲溶液中释放。  相似文献   

9.
测定了十二烷基磺酸钠(SDS)在载银离子纳米TiO2颗粒表面的等温吸附曲线,在SDS达到临界胶束浓度(CMC)时,研究了pH=2.0(等电点以下)和pH=7.0(等电点以上)时甲基丙烯酸甲酯(MMA)在TiO2粒子表面的乳液聚合.采用改性前后TiO2的Zeta 电位的变化、红外光谱(FT-IR)及差热分析(DTA)等表征方法评价了改性效果.结果表明:PMMA成功包覆到TiO2表面,包覆率达17.8%,载银TiO2的表面由亲水变为亲油;在pH=2.0,cSDS=5.0 mmol/L时,Ag+的脱附量只有8%.  相似文献   

10.
用聚丙烯酸叔丁酯-b-聚乙二醇(PtBA45-b-PEG114)和聚丙烯酸叔丁酯-b-聚4-乙烯基吡啶(PtBA60-b-P4VP80)制备了复合胶束. 该胶束在pH=2.5的酸性水溶液中形成以PtBA为核, PEG和P4VP为壳的稳定球型结构. 在pH=12时, 壳层的P4VP链段变为疏水, 塌缩在PtBA的核上形成内壳, PEG链段继续保持溶解状态, 与成核的PtBA连接并穿过塌陷的P4VP内壳, 形成胶束的冠, 由于PEG处于溶解状态, 其分子链间有比较大的空隙, 可以控制一些小分子通过, 在胶束的表面形成通道. 该通道类似于生物膜的蛋白通道, 可以控制PtBA核与外界进行能量或物质交换的速度. 以布洛芬为模型分子, 负载在胶束内进行药物控制释放研究的结果表明, 胶束表面的通道可以起到明显控制布洛芬释放速度的作用, 并且药物的释放速度与通道在胶束表面的比例成正比.  相似文献   

11.
A loading of ramipril in SBA-15 (Santa Barbara Amorphous) mesoporous material was studied. (SBA-15)-ramipril composite material was characterized by chemical analysis, infrared spectroscopy, powder X-ray diffraction, low temperature N2 adsorption–desorption at 77 K characterization techniques. Ramipril drug release processes from SBA-15 host to simulated body fluid (SBF), simulated gastric juice (SGJ), simulated intestinal fluid (SIF) were monitored in a simulated way and actions of the sustained release of (SBA-15)-ramipril was studied. The results showed that the loading amount of ramipril drug in SBA-15 was 90.30 mg/g. The cumulative sustained release rate of ramipril composite drug in SBF achieved 99.7 % after 27 h. When the sustained release of composite drug in SGJ was 8 h, the maximum cumulative sustained release ratio achieved 54.9 %. When the sustained release of composite drug was 9 h in SIF, the maximum cumulative sustained release ratio achieved 34.9 %. The method described in this study is suitable for carrying ramipril drug on SBA-15, and a new carrier to load ramipril drug was found. Meanwhile, the efficacy of ramipril drug and time efficacy could be improved.  相似文献   

12.
Two types of mesoporous silica nanospheres (MSNs) were synthesized for use as controlled-release agents. One was prepared by grafting with 5,6-dihydroxyhexylsilane (DH-MSN) and the other one by further coating with cholic acid-crosslinked poly(lactic acid) (CA-PLA-MSN). We studied the release of the antidepressant venlafaxine from each of the materials in simulated gastric fluid (SGF), in simulated gastric acid solution (SGA), and in simulated intestinal fluid without pancreatin (SIF). The CA-PLA-MSN material was able to significantly delay the release of the drug in intestinal condition compared with gastric acid surrounding due to the fast decomposition rate of PLA in gastric acid. Moreover, it successfully avoided the initial burst to a certain extent in SGF. The enzyme pepsin played a favorable obstruct role in both DH-MSN and CA-PLA-MSN systems to reduce release rate. A model based on Weibull model was built to fit the release results, and based on it, the mechanisms about release processes were brought out tentatively.  相似文献   

13.
Controlled drug release from bifunctionalized mesoporous silica   总被引:2,自引:0,他引:2  
Serial of trimethylsilyl-carboxyl bifunctionalized SBA-15 (TMS/COOH/SBA-15) have been studied as carriers for controlled release of drug famotidine (Famo). To load Famo with large capacity, SBA-15 with high content of carboxyl groups was successfully synthesized by one-pot synthesis under the assistance of KCl. The mesostructure of carboxyl functionalized SBA-15 (COOH/SBA-15) could still be kept even though the content of carboxyl groups was up to 57.2%. Increasing carboxyl content could effectively enhance the loading capacity of Famo. Compared with pure SBA-15, into which Famo could be hardly adsorbed, the largest drug loading capacity of COOH/SBA-15 could achieve 396.9 mg/g. The release of Famo from mesoporous silica was studied in simulated intestine fluid (SIF, pH=7.4). For COOH/SBA-15, the release rate of Famo decreased with narrowing pore size. After grafting TMS groups on the surface of COOH/SBA-15 with hexamethyldisilazane, the release of Famo was greatly delayed with the increasing content of TMS groups.  相似文献   

14.
Propranolol hydrochloride was incorporated into SBA-15 mesoporous material host by impregnation method to obtain host-guest nanocomposite material (SBA-15)-propranolol hydrochloride. By spectrophotometry, the amount of propranolol hydrochloride assembly was determined to be 382.05?mg/g (drug/SBA-15). Powder X-ray diffraction test results indicated that during the process of incorporation the framework of the molecular sieve was not destroyed and the molecular sieve still remained its structure ordering. Fourier transform infrared spectra showed that the framework of the prepared host-guest material was remained in good condition. Low-temperature nitrogen adsorption-desorption at 77?K results showed that the surface area and the pore volume of (SBA-15)-propranolol hydrochloride host-guest material decreased compared to those of the host molecular sieve, indicating that propranolol hydrochloride guest molecules have partially occupied the channels of the molecular sieve. Transmission electron microscopy and scanning electron microscopy results indicated that two-dimensional hexagonal mesoporous pore channels of the molecular sieve were retained and (SBA-15)-propranolol hydrochloride composite material remained fibrous crystals and the average diameter of sample was 336?nm. It was discovered in drug release principle in the simulated body fluid that the effective release time of the drug reached 30?h and the maximum cumulative released amount of propranolol hydrochloride was 99.3?%. When drug release time arrived at 5?h in the simulated gastric juice, the maximum cumulative released amount was 51.2?%.When drug release time arrived at 9?h in the simulated intestinal fluid, the maximum cumulative released amount was 70.1?%. The drug sustained release results showed that SBA-15 is a well-controlled drug release carrier.  相似文献   

15.
Porous chitosan (CS) polyelectrolyte complex (PEC) hydrogel microspheres were prepared via either wet phase-inversion or ionotropic crosslinking with sodium tripolyphosphate (Na+ - TPP) and dextran sulfate (DS). The resulting microspheres were characterized using scanning electron microscopy (SEM) and elemental analysis (EA). The controlled release behavior of ibuprofen (IBU) from these microspheres was investigated. The PEC microspheres were about 700-950 microm in diameter with large pores and open porous structure. The CS/TPP/DS microspheres resisted hydrolysis in strong acid and biodegradation in enzymatic surroundings. The swelling kinetics for CS microspheres was close to Fickian diffusion, whereas those for CS/TPP and CS/TPP/DS were non-Fickian. Furthermore, the equilibrium water content (EWC) and water diffusion coefficient (D) increased with the pH of the media. The release profiles of IBU from CS/TPP/DS microspheres were slow in simulated gastric fluid (SGF, pH 1.4) over 3 h, but nearly all of the initial drug content was released in simulated intestinal fluid (SIF, pH 6.8) within 6 h after changing media. Overall the results demonstrated that CS/TPP/DS microspheres could successfully deliver a hydrophobic drug to the intestine without losing the drug in the stomach, and hence could be potential candidates as an orally administered drug delivery system.  相似文献   

16.
pH-Controllable drug release using hydrogel encapsulated mesoporous silica   总被引:1,自引:0,他引:1  
Amine-functionalized mesoporous SBA-15 silica loaded with bovine serum albumin (BSA) has been successfully encapsulated with a thin layer coating of poly(acrylic acid) PAA, with the entrapped BSA being released from the PAA-encapsulated SBA-15 at the higher pH value of 7.4 rather than at the lower pH value of 1.2. This novel drug delivery system has a potential application in the release of protein drug to the site of higher pH value, such as small intestine or colon.  相似文献   

17.
The present work describes the dynamic release of model drug riboflavin form uncoated and ethyl cellulose coated barium alginate beads in the media of continuous varying pH at the physiological temperature 37°C. The drug release behavior has been studied in the simulating gastric fluid (SGF, pH 1.2) for 0–2 h and then in the simulating intestinal fluid (SIF pH 6.8) for 2–48 h. In addition to the traditional dissolution test (TDT, the dynamic release has also been studied by a newly developed method, called ‘flow through diffusion cell’ (FTDC). The release profiles, obtained by using these two methods have been found to differ appreciably from each other. Moreover, the nature of the solid mass surrounding the beads in the FTDC method also influences the release behavior of beads. The uncoated beads demonstrated faster drug release of drug in the medium of lower pH (i.e., 1.2) as compared to that in the medium of pH 6.8 and the release process was found to be diffusion controlled.  相似文献   

18.
A novel and well-defined pH-sensitive amphiphilic triblock copolymer brush poly(lactide)-b-poly(methacrylic acid)-b-poly(poly(ethylene glycol) methyl ether monomethacrylate) (PLA-b-PMAA-b-PPEGMA) and its self-assembled micelles were developed for oral administration of hydrophobic drugs. The copolymer and its precursors were synthesized by the combination of activators regenerated by electron transfer atom transfer radical polymerization (ARGET ATRP) and ring-opening polymerization (ROP) techniques. The molecular structures and characteristics were confirmed by GPC, (1)H NMR, and FT-IR. The critical micelle concentration (CMC) values of PLA-b-PMAA-b-PPEGMA in aqueous medium varied from 1.4 to 2.6 mg/L, and the partition equilibrium constant (K(v)) of pyrene in micellar solutions ranged from 2.873 × 10(5) to 3.312 × 10(5). The average sizes of the self-assembled blank and drug-loaded micelles were 140-250 nm determined by DLS in aqueous solution. The morphology of the micelles was found to be spherical by SEM. Nifedipine (NFD), a poorly water-soluble drug, was selected as the model drug and wrapped into the core of micelles via dialysis method. The in vitro release behavior of NFD from the micelles was pH-dependent. In simulated gastric fluid (SGF, pH 1.2), the cumulative release percent of NFD was relative low, while in simulated intestinal fluid (SIF, pH 7.4), more than 96% was released within 24 h. All the results showed that the pH-sensitive PLA-b-PMAA-b-PPEGMA micelle may be a prospective candidate as oral drug delivery carrier for hydrophobic drugs with controlled release behavior.  相似文献   

19.
Because of the growing importance of pH‐sensitive hydrogels as drug delivery systems, biocompatible copolymeric hydrogels based N‐vinyl‐2‐pyrrolidinone (NVP) and methacrylic acid (MAA) were designed and synthesized. These hydrogels were investigated for oral drug delivery. Radical copolymerizations of N‐vinyl‐2‐pyrrolidinone (NVP) and methacrylic acid (MAA) with the various ratios of cross‐linking agent were carried out at 70 °C. Azabisisobutyronitrile (AIBN) was the free‐radical initiator employed and Cubane‐1,4‐dicarboxylic acid (CDA) linked to two 2‐hydroxyethyl methacrylate (HEMA) group was the crosslinking agent (CA) used for hydrogel preparations. The hydrogels were characterized by differential scanning calorimetry and FT‐IR. Equilibrium swelling studies were carried out in enzyme‐free simulated gastric and intestinal fluids (SGF and SIF, respectively). A model drug, olsalazine [3,3′‐azobis (6‐hydroxy benzoic acid)] (OSZ) as an azo derivative of 5‐aminosalicylic acid (5‐ASA), was entrapped in these gels and the in‐vitro release profiles were established separately in both enzyme‐free SGF and SIF. The drug‐release profiles indicated that the amount of drug released depended on the degree of swelling. The swelling was modulated by the amount of crosslinking of the polymer bonded drug (PBDs) prepared. Based on the great difference in hydrolysis rates at pH 1 and 7.4, these pH‐sensitive hydrogels appear to be good candidates for colon‐specific drug delivery.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号